Guru Chahal, Partner @ Lightspeed
Guru Chahal reflects on his two-decade reconnection with Kevin Weil and their shared investment in Warp, a U.S.-based contract research organization using AI and robotics to accelerate drug discovery by automating chemistry synthesis and closing the experimental bottleneck in preclinical development.
Read the full post on Guru Chahal ↗
Topics: Biotech & Life Sciences · AI (Horizontal)
Published by Guru Chahal · their site ↗
SandHill indexes 800+ venture capital blogs and newsletters and sends the best of them every Sunday. Browse the sources · browse by topic · read the blog.
Suggest a blog or newsletter for the SandHill index. We track the RSS feed and feature the best pieces in the weekly digest.
The latest theses & analyses from 800+ venture investors, curated into one email. Join 5,000+ investors, founders and LPs.